Target
Major surface glycoprotein G
Ligand
BDBM194731
Substrate
n/a
Meas. Tech.
Viral Cytopathic Effect (CPE) Assay
Citation
 Gao, LGuo, LLiang, CWang, BWang, LYun, HZhang, WZheng, X Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection US Patent  US9670211 Publication Date 6/6/2017 
Target
Name:
Major surface glycoprotein G
Synonyms:
Attachment glycoprotein G | G | GLYC_HRSV | Membrane-bound glycoprotein | mG
Type:
Protein
Mol. Mass.:
32805.15
Organism:
Human respiratory syncytial virus A (strain Long)
Description:
P20895
Residue:
298
Sequence:
MSKNKDQRTAKTLEKTWDTLNHLLFISSGLYKLNLKSIAQITLSILAMIISTSLIITAIIFIASANHKVTLTTAIIQDATSQIKNTTPTYLTQDPQLGISFSNLSEITSQTTTILASTTPGVKSNLQPTTVKTKNTTTTQTQPSKPTTKQRQNKPPNKPNNDFHFEVFNFVPCSICSNNPTCWAICKRIPNKKPGKKTTTKPTKKPTFKTTKKDLKPQTTKPKEVPTTKPTEEPTINTTKTNITTTLLTNNTTGNPKLTSQMETFHSTSSEGNLSPSQVSTTSEHPSQPSSPPNTTRQ
  
Inhibitor
Name:
BDBM194731
Synonyms:
US9670211, 1-1
Type:
Small organic molecule
Emp. Form.:
C22H21ClN4O3S
Mol. Mass.:
456.945
SMILES:
CS(=O)(=O)[C@@H]1C[C@@H](C1)n1c(CN2C(=O)C3(CC3)c3ccncc23)nc2cc(Cl)ccc12 |r,wD:6.8,4.3,(.31,6.89,;.31,5.35,;-1.23,5.35,;1.85,5.35,;.31,3.81,;1.08,2.48,;-.25,1.71,;-1.02,3.04,;-.65,.22,;.25,-1.03,;1.79,-1.03,;2.56,-2.36,;4.1,-2.36,;4.87,-1.03,;4.58,-3.83,;5.35,-5.16,;6.12,-3.83,;3.33,-4.73,;3.17,-6.26,;1.76,-6.89,;.52,-5.98,;.68,-4.45,;2.09,-3.83,;-.65,-2.27,;-2.12,-1.8,;-3.45,-2.57,;-4.78,-1.8,;-6.12,-2.57,;-4.78,-.26,;-3.45,.51,;-2.12,-.26,)|
Structure:
Search PDB for entries with ligand similarity: